2型糖尿病伴血脂异常患者外周血白细胞及淋巴细胞的变化与临床意义

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (410 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the change of leukocytes, lymphocytes and ratio of lymphocytes and the clinical significance in type 2 diabetic patients with dyslipidemia. Methods We collected venous blood from 225 type 2 diabetes patients with dyslipidemia and 109 type 2 diabetes patients with normal lipid,then analyzed difference in blood routine between the two groups. Results (1)The leukocyte count in type 2 diabetes patients with dyslipidemia was[(6.50±1.60)×10⁹/L] and in type 2 diabetes with normal lipid was[(6.30±1.63) ×10⁹/L],the without P value is 0.326( greater than 0.05).statically significant difference.(2)The number of lymphocytes in type 2 diabetes patients with dyslipidemia was[(2.08±0.74)×10⁹/L] and in type 2 diabetes patients with normal lipid was[(1.89±0.60)×10⁹/L,P=0.012],the P value is 0.012 (less than 0.05).(3)The leukocyte tlymphocyte ratio in type 2 diabetes patients with dyslipidemia was(0.32±0.091) and in type 2 diabetes psstients with normal lipid was(0.31±0.089).the P value is0.016 ( less than 0.05).In the two groups,the lymphocyte cell count and leukocyted lymphocyte ratio has statically significant difference Conclusions In patients with type 2 diabetes ,dyslipidemia causes change in the number of lymphocytes and may beengaged in certain inflammatory reaction.

Key words： leukocytes lymphocytes dyslipidemia type 2 diabetes chronic inflammation

Received: 11 December 2015

ZTFLH:

R589.2

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LUO Lijun
	XU Chenggao
	SHI Xiaoyun
	and WANG Xiangdang

Cite this article:

LUO Lijun,XU Chenggao,SHI Xiaoyun等. Changes and clinical significance of leukocytes and lymphocytes in patients with type 2 diabetes and dyslipidemia[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2016, 27(5): 447-448.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2016/V27/I5/447

[1]	刘志民,刘子毓.代谢综合征研究现状及展望[J]. 中华老年心脑血管病杂志,2015,17(4):337-338.
[2]	虎静,雷涛.血脂紊乱与骨质疏松关系的研究进展[J]. 中国骨质疏松杂志,2014,20(6): 337-338.
[3]	Suzan M. Hyperlipidemia in rheumatoid arthritis patients in Saudi Arabia[J]. Saudi Med,2015,36(6):685-691.
[4]	Leila G H, Faramarz Z,Fatemeh H, et al. The Association Between Hyperlipidemia and Periodontal Infection[J]. Iran Red Crescent Med,2014, 16(12): e6577.
[5]	Shehab M. Non-alcoholic fatty liver disease: The diagnosis and management[J]. World J Hepatol,2015,7(6):846-858.
[6]	American Diabetes Association. Standards of medical care in diabetes—2014[J]. Diabetes Care,2014,37(Suppl 1):S14-S80.
[7]	贺斌,陈剑,程金山,等. 2型糖尿病患者外周血白细胞计数与尿白蛋白相关性的分析[J].中国药科学杂志,2012,9(17):58-60.
[8]	迟林,李昊森,许晓风,等.2型糖尿病患者外周血淋巴细胞亚群及Treg细胞检测及临床应用[J].山东医药杂志,2011,51(40):87-89.
[9]	王小林,明军,王永红,等. 白细胞总数及分类与血脂异常的相关性观察[J]. 中国老年学杂志, 2011,3(31):391-393.
[10]	Mehta J L, Li D Y. Inflammation in is chemic heart disease: response to tissue Injury orapathogenetic villain[J].CardiovascRes, 1999,43(2):291-299.